Fall35% Off Sitewide

Code…

For laboratory research use only — not for human or veterinary use. Not evaluated by the U.S. FDA.

AOD-9604 — studio product photo

Cellular Peptide

AOD-9604

Anti-Obesity Drug 9604hGH Fragment 177-191Tyr-hGH177-191

A synthetic analog of the C-terminal lipolytic domain of growth hormone (residues 177–191 with an added N-terminal tyrosine), examined in animal studies of lipolytic signaling.

Size

Quantity

1

$29.99

Bundle & save

What's the reconstitution solution? →

Order by 3:00 PM ET for same-day dispatch

Cutoff 3:00 PM ET · same-day dispatch

Estimated arrival in 2 business days

Overnight shipping available

Free shipment protection included

Free shipping over $150 Secure 256-bit SSL checkout

AOD-9604

1 × 2mg · $29.99

99% purity, QC passed

HPLC + mass-spec verified

Shipment protection

Free on every order

Free shipping over $150

Same-day dispatch before 3PM ET

About AOD-9604

Structure and research context

AOD-9604 is a synthetic peptide analogue of the lipolytic domain located at the C-terminus of growth hormone. Its sequence corresponds to residues 177 to 191 of the native hormone extended by an N-terminal tyrosine, giving the molecular formula C78H123N23O23S2 and a molar mass of about 1,815 g/mol. The fragment was developed to study the lipid-metabolism activity attributed to this region separately from the rest of the parent protein, and it has been examined side by side with the intact hormone in rodent research.

AOD-9604 in the research literature

In Zucker rats, chronic exposure to AOD-9604 was reported to increase lipolytic activity in adipose tissue, and insulin-sensitivity measurements in the same work did not show the change observed with chronic exposure to the intact hormone. Mouse studies found that both the fragment and intact growth hormone raised beta3-adrenergic receptor RNA expression in adipose tissue. Experiments in beta3-adrenergic receptor knockout mice indicated that the lipolytic actions are not mediated directly through that receptor, although acute measurements in the knockout animals still showed increased energy expenditure and lipid oxidation.

Separately, a rabbit model of collagenase-induced cartilage degeneration examined AOD-9604 alone and combined with hyaluronic acid, reporting lower morphological and histopathological degeneration scores than in control joints.

Summarized from peer-reviewed literature for research context only; not a product claim. PubMed: 11146367 · 11713213 · 26275694

AOD-9604 Certificate of Analysis

Third-party tested · Independent analytical lab

6 recent lots on file

5mg

99.78%latest

TestedMeasuredPurity
Jul 20265.20mg99.78%
Jun 20265.21mg99.71%
Apr 20265.65mg99.72%
Feb 20265.84mg99.08%
Nov 20255.13mg99.33%
Oct 20254.92mg99.33%

Frequently researched together

Commonly studied alongside AOD-9604.

Compound information

Technical specifications

Molecular profile

TypeModified peptide fragment
CAS number221231-10-3
Molecular weight1,815.1 g/mol
Amino acids15
SequenceTyr-hGH(177-191)
FormulaC78H123N23O23S2
View on PubChem

Storage & stability

Lyophilized: -20°CReconstituted: 2–8°CProtect from light
  • ❄️

    Lyophilized (powder)

    -20°C · stable 2+ years

  • ❄️

    Reconstituted

    2–8°C · use within 30 days

AOD-9604 sources & references

Peer-reviewed literature, for research context

More in Metabolic

Every Metabolic research compound in the catalog.

Important research notice

Not for human consumption. This product is sold exclusively for laboratory and in vitro research. It is not intended to diagnose, treat, cure, or prevent any disease.

Any research findings referenced on this page are drawn from published, peer-reviewed literature and are provided for educational context only. They are not product claims and should not be read as medical advice.

By purchasing, you confirm you are a qualified researcher and will handle this material in accordance with all applicable laws and institutional guidelines.